Benedetta Conte
Grup de recerca
- Genòmica translacional i teràpies dirigides en tumors sòlids Pre-doctoral researcher (R1)
Publicacions destacades
-
Adding a platinum agent to neoadjuvant chemotherapy for triple negative breast cancer: the end of the debate
Autors:Referència: Annals Of Oncology 2022. -
Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy
Autors:Referència: Clinical Cancer Research 2021. -
Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis
Autors:Referència: Cancers 2021. -
Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy
Autors:Referència: Npj Breast Cancer 2021. -
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation
Autors:Referència: Lancet Oncology 2020. -
Frequency and spectrum of PIK3CA somatic mutations in breast cancer
Autors:Referència: Breast Cancer Research 2020. -
HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis
Autors:Referència: Cancer Treatment Reviews 2020. -
Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer
Autors:Referència: Cancers 2020. -
Effect of dose-dense adjuvant chemotherapy in hormone receptor positive/HER2-negative early breast cancer patients according to immunohistochemically defined luminal subtype: an exploratory analysis of the GIM2 trial
Autors:Referència: European Journal Of Cancer 2020. -
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreak
Autors:Referència: European Journal Of Clinical Investigation 2020.